Immune-Mediated Encephalopathies with an Emphasis on Paraneoplastic Encephalopathies

ABSTRACT

Recent identification of syndromes encompassing psychiatric symptoms, seizures, and movement disorders has led to effective treatments for several previously obscure conditions now known to be immune-mediated encephalopathies. In contrast to long-recognized paraneoplastic neurologic syndromes associated with antibodies to intracellular antigens, these more recently described disorders are not always paraneoplastic, are associated with cell surface antibodies, and may respond to immunosuppressive therapies. In this review, the author discusses clinical presentations, differential diagnosis, immunologic evaluation, and therapeutic options for both groups of disorders.

KEYWORDS

Paraneoplastic syndromes - limbic encephalitis - NMDAR encephalitis - voltage-gated potassium channel antibodies

REFERENCES

• 1 Rosenfeld M R, Dalmau J. Update on paraneoplastic and autoimmune disorders of the central nervous system.  Semin Neurol. 2010;  30 (3) 320-331
• 2 Antoine J C, Camdessanché J P. Peripheral nervous system involvement in patients with cancer.  Lancet Neurol. 2007;  6 (1) 75-86
• 3 Rudnicki S A, Dalmau J. Paraneoplastic syndromes of the peripheral nerves.  Curr Opin Neurol. 2005;  18 (5) 598-603
• 4 Flanagan E P, McKeon A, Lennon V A et al.. Autoimmune dementia: clinical course and predictors of immunotherapy response.  Mayo Clin Proc. 2010;  85 (10) 881-897
• 5 Vernino S, Geschwind M, Boeve B. Autoimmune encephalopathies.  Neurologist. 2007;  13 (3) 140-147
• 6 Vincent A, Irani S R, Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins.  Curr Opin Neurol. 2010;  23 (2) 144-150
• 7 Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS.  J Neurol. 2010;  257 (4) 509-517
• 8 Dalmau J, Rosenfeld M R. Paraneoplastic syndromes of the CNS.  Lancet Neurol. 2008;  7 (4) 327-340
• 9 Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. PNS Euronetwork . Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.  Arch Neurol. 2010;  67 (3) 330-335
• 10 Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment.  Neurologist. 2007;  13 (5) 261-271
• 11 Josephs K A, Ahlskog J E, Parisi J E et al.. Rapidly progressive neurodegenerative dementias.  Arch Neurol. 2009;  66 (2) 201-207
• 12 Geschwind M D, Shu H, Haman A, Sejvar J J, Miller B L. Rapidly progressive dementia.  Ann Neurol. 2008;  64 (1) 97-108
• 13 Graus F, Saiz A, Lai M et al.. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.  Neurology. 2008;  71 (12) 930-936
• 14 McKeon A, Ahlskog J E, Britton J A, Lennon V A, Pittock S J. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images.  Arch Neurol. 2009;  66 (2) 268-271
• 15 Dalmau J, Graus F, Villarejo A et al.. Clinical analysis of anti-Ma2-associated encephalitis.  Brain. 2004;  127 (Pt 8) 1831-1844
• 16 Castle J, Sakonju A, Dalmau J, Newman-Toker D E. Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease.  Nat Clin Pract Neurol. 2006;  2 (10) 566-572, quiz 573
• 17 Saiz A, Bruna J, Stourac P et al.. Anti-Hu-associated brainstem encephalitis.  J Neurol Neurosurg Psychiatry. 2009;  80 (4) 404-407
• 18 Pittock S J, Debruyne J, Krecke K N et al.. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).  Brain. 2010;  133 (9) 2626-2634
• 19 Heinrich A, Vogelgesang S, Kirsch M, Khaw A V. Intravascular lymphomatosis presenting as rapidly progressive dementia.  Eur Neurol. 2005;  54 (1) 55-58
• 20 Sips G J, Amory C F, Delman B N, Kleinman G M, Lipsey L R, Tuhrim S. Intravascular lymphomatosis of the brain in a patient with myelodysplastic syndrome.  Nat Rev Neurol. 2009;  5 (5) 288-292
• 21 Carney C P, Jones L, Woolson R F, Noyes Jr R, Doebbeling B N. Relationship between depression and pancreatic cancer in the general population.  Psychosom Med. 2003;  65 (5) 884-888
• 22 Turaga K K, Malafa M P, Jacobsen P B, Schell M J, Sarr M G. Suicide in patients with pancreatic cancer.  Cancer. 2011;  117 (3) 642-647
• 23 Silverman D H, Dy C J, Castellon S A et al.. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.  Breast Cancer Res Treat. 2007;  103 (3) 303-311
• 24 Joshi G, Aluise C D, Cole M P et al.. Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain.  Neuroscience. 2010;  166 (3) 796-807
• 25 Suzuki H I, Hangaishi A, Hosoya N et al.. Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: a case report and literature review.  Int J Hematol. 2008;  87 (5) 538-541
• 26 Pruitt A A, Dalmau J, Detre J, Alavi A, Rosenfeld M R. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation.  Neurology. 2006;  67 (4) 676-678
• 27 Quan D, Hackney D B, Pruitt A A, Lenkinski R E, Cecil K M. Transient MRI enhancement in a patient with seizures and previously resected glioma: use of MRS.  Neurology. 1999;  53 (1) 211-213
• 28 Seeley W W, Marty F M, Holmes T M et al.. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.  Neurology. 2007;  69 (2) 156-165
• 29 Airas L, Päivärinta M, Röyttä M et al.. Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT.  Bone Marrow Transplant. 2010;  45 (3) 593-596
• 30 Weathers A L, Lewis S L. Rare and unusual ... or are they? Less commonly diagnosed encephalopathies associated with systemic disease.  Semin Neurol. 2009;  29 (2) 136-153
• 31 Salvarani C, Brown Jr R D, Calamia K T et al.. Primary central nervous system vasculitis: analysis of 101 patients.  Ann Neurol. 2007;  62 (5) 442-451
• 32 Desestret V, Didelot A, Meyronet D, Bruyas A, Jouvet A, Honnorat J. Neurosarcoidosis with diencephalitis and anti-Ma2 antibodies.  Neurology. 2010;  74 (9) 772-774
• 33 Zandman-Goddard G, Chapman J K, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome.  Semin Arthritis Rheum. 2007;  36 (5) 297-315
• 34 Kimura A, Kanoh Y, Sakurai T et al.. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.  Neurology. 2010;  74 (17) 1372-1379
• 35 Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren S I. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors.  Eur J Neurol. 2005;  12 (5) 392-398
• 36 Kruer M C, Koch T K, Bourdette D N et al.. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.  Neurology. 2010;  74 (18) 1473-1475
• 37 Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma.  Ann Neurol. 2005;  58 (4) 594-604
• 38 Dalmau J, Tüzün E, Wu H Y et al.. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma.  Ann Neurol. 2007;  61 (1) 25-36
• 39 Sansing L H, Tüzün E, Ko M W, Baccon J, Lynch D R, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies.  Nat Clin Pract Neurol. 2007;  3 (5) 291-296
• 40 Hughes E G, Peng X, Gleichman A J et al.. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.  J Neurosci. 2010;  30 (17) 5866-5875
• 41 Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M R, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.  Lancet Neurol. 2011;  10 (1) 63-74
• 42 Eker A, Saka E, Dalmau J et al.. Testicular teratoma and anti-N-methyl-d-aspartate receptor-associated encephalitis.  J Neurol Neurosurg Psychiatry. 2008;  79 (9) 1082-1083
• 43 Lebas A, Husson B, Didelot A, Honnorat J, Tardieu M. Expanding spectrum of encephalitis with NMDA receptor antibodies in young children.  J Child Neurol. 2010;  25 (6) 742-745
• 44 Zandi M S, Irani S R, Follows G, Moody A M, Molyneux P, Vincent A. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma.  Neurology. 2009;  73 (23) 2039-2040
• 45 Irani S R, Bera K, Waters P et al.. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.  Brain. 2010;  133 (Pt 6) 1655-1667
• 46 Florance N R, Davis R L, Lam C et al.. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents.  Ann Neurol. 2009;  66 (1) 11-18
• 47 Baltagi S A, Shoykhet M, Felmet K, Kochanek P M, Bell M J. Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic.  Pediatr Crit Care Med. 2010;  11 (2) 179-184
• 48 Ferioli S, Dalmau J, Kobet C A, Zhai Q J, Broderick J P, Espay A J. Anti-N-methyl-d-aspartate receptor encephalitis: characteristic behavioral and movement disorder.  Arch Neurol. 2010;  67 (2) 250-251
• 49 Wong-Kisiel L C, Ji T, Renaud D L et al.. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.  Neurology. 2010;  74 (19) 1550-1551
• 50 Labate A, Irani S R, Vincent A et al.. Anti-NMDA receptor encephalitis: a video case report.  Epileptic Disord. 2009;  11 (3) 267-269
• 51 Dalmau J, Gleichman A J, Hughes E G et al.. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.  Lancet Neurol. 2008;  7 (12) 1091-1098
• 52 González-Valcárcel J, Rosenfeld M R, Dalmau J. Differential diagnosis of encephalitis due to anti-NMDA receptor antibodies.  Neurologia. 2010;  25 (7) 409-413
• 53 Sébire G. In search of lost time from “demonic possession” to anti-N-methyl-d-aspartate receptor encephalitis.  Ann Neurol. 2010;  67 (1) 141-142, author reply 142–143
• 54 Iizuka T, Sakai F, Ide T et al.. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.  Neurology. 2008;  70 (7) 504-511
• 55 Sabin T D, Jednacz J A, Staats P N. Case records of the Massachusetts General Hospital. Case 26-2008. A 26-year-old woman with headache and behavioral changes.  N Engl J Med. 2008;  359 (8) 842-853
• 56 Niehusmann P, Dalmau J, Rudlowski C et al.. Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy.  Arch Neurol. 2009;  66 (4) 458-464
• 57 Prüss H, Dalmau J, Harms L et al.. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.  Neurology. 2010;  75 (19) 1735-1739
• 58 Dale R C, Irani S R, Brilot F et al.. N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica.  Ann Neurol. 2009;  66 (5) 704-709
• 59 Gable M S, Gavali S, Radner A et al.. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis.  Eur J Clin Microbiol Infect Dis. 2009;  28 (12) 1421-1429
• 60 Bataller L, Galiano R, García-Escrig M et al.. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor.  Neurology. 2010;  74 (3) 265-267
• 61 Graus F, Boronat A, Xifró X et al.. The expanding clinical profile of anti-AMPA receptor encephalitis.  Neurology. 2010;  74 (10) 857-859
• 62 Lai M, Hughes E G, Peng X et al.. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.  Ann Neurol. 2009;  65 (4) 424-434
• 63 Lancaster E, Lai M, Peng X et al.. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.  Lancet Neurol. 2010;  9 (1) 67-76
• 64 Hutchinson M, Waters P, McHugh J et al.. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.  Neurology. 2008;  71 (16) 1291-1292
• 65 Clerinx K, Breban T, Schrooten M et al.. Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy.  Neurology. 2011;  76 (3) 303-304
• 66 Moscato E H, Jain A, Peng X, Hughes E G, Dalmau J, Balice-Gordon R J. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.  Eur J Neurosci. 2010;  32 (2) 298-309
• 67 Belforte J E, Zsiros V, Sklar E R et al.. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.  Nat Neurosci. 2010;  13 (1) 76-83
• 68 Vincent A, Buckley C, Schott J M et al.. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.  Brain. 2004;  127 (Pt 3) 701-712
• 69 Iranzo A, Graus F, Clover L et al.. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis.  Ann Neurol. 2006;  59 (1) 178-181
• 70 McKnight K, Jiang Y, Hart Y et al.. Serum antibodies in epilepsy and seizure-associated disorders.  Neurology. 2005;  65 (11) 1730-1736
• 71 Irani S R, Alexander S, Waters P et al.. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.  Brain. 2010;  133 (9) 2734-2748
• 72 Reid J M, Foley P, Willison H J. Voltage-gated potassium channel-associated limbic encephalitis in the West of Scotland: case reports and literature review.  Scott Med J. 2009;  54 (4) 27-31
• 73 Geschwind M D, Tan K M, Lennon V A et al.. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease.  Arch Neurol. 2008;  65 (10) 1341-1346
• 74 Tan K M, Lennon V A, Klein C J, Boeve B F, Pittock S J. Clinical spectrum of voltage-gated potassium channel autoimmunity.  Neurology. 2008;  70 (20) 1883-1890
• 75 McKeon A, Marnane M, O'Connell M, Stack J P, Kelly P J, Lynch T. Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome.  Arch Neurol. 2007;  64 (10) 1528-1530
• 76 Fukata Y, Lovero K L, Iwanaga T et al.. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy.  Proc Natl Acad Sci U S A. 2010;  107 (8) 3799-3804
• 77 Lai M, Huijbers M GM, Lancaster E et al.. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.  Lancet Neurol. 2010;  9 (8) 776-785
• 78 Vincent A. Antibodies to contactin-associated protein 2 (CASPR2) in thymoma and Morvan's syndrome.  Ann Neurol. 2009;  66 (Suppl 13) S3
• 79 Saiz A, Blanco Y, Sabater L et al.. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.  Brain. 2008;  131 (Pt 10) 2553-2563
• 80 Malter M P, Helmstaedter C, Urbach H, Vincent A, Bien C G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.  Ann Neurol. 2010;  67 (4) 470-478
• 81 Psimaras D, Carpentier A F, Rossi C. PNS Euronetwork . Cerebrospinal fluid study in paraneoplastic syndromes.  J Neurol Neurosurg Psychiatry. 2010;  81 (1) 42-45
• 82 Bataller L, Wade D F, Graus F, Stacey H D, Rosenfeld M R, Dalmau J. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer.  Neurology. 2004;  62 (5) 778-782
• 83 Bernal F, Graus F, Pifarré A, Saiz A, Benyahia B, Ribalta T. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis.  Acta Neuropathol. 2002;  103 (5) 509-515
• 84 Titulaer M J, Soffietti R, Dalmau J et al.. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.  Eur J Neurol. 2011;  18 (1) 19-e3
• 85 McKeon A, Apiwattanakul M, Lachance D H et al.. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review.  Arch Neurol. 2010;  67 (3) 322-329
• 86 Mathew R M, Vandenberghe R, Garcia-Merino A et al.. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.  Neurology. 2007;  68 (12) 900-905
• 87 Erkmen C P, Fadul C E, Dalmau J, Erkmen K. Thymoma-associated paraneoplastic encephalitis (TAPE): diagnosis and treatment of a potentially fatal condition.  J Thorac Cardiovasc Surg. 2011;  141 (2) e17-e20
• 88 Rosenfeld M R, Dalmau J. Current therapies for paraneoplastic neurologic syndromes.  Curr Treat Options Neurol. 2003;  5 (1) 69-77
• 89 Lehmann H C, Hartung H P, Hetzel G R, Stüve O, Kieseier B C. Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders.  Arch Neurol. 2006;  63 (7) 930-935
• 90 Raju R, Rakocevic G, Chen Z et al.. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome.  Brain. 2006;  129 (Pt 12) 3270-3276